 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Simulations Plus (NASDAQ:SLP - Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.66-0.68 for the...

Simulations Plus (NASDAQ:SLP) Issues FY24 Earnings Guidance

Simulations Plus (NASDAQ:SLP - Get Free Report) announced its quarterly earnings data on Wednesday. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping the...

Simulations Plus (NASDAQ:SLP) Issues  Earnings Results

Simulations Plus (NASDAQ:SLP - Get Free Report) released its earnings results on Wednesday. The technology company reported $0.20 earnings per share for the quarter, topping analysts' consensus...

Simulations Plus (NASDAQ:SLP) Releases  Earnings Results, Beats Estimates By $0.02 EPS

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that the...

U.S. FDA Renews DILIsym Software Licenses for 7th Year

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an...

Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock

Shares of Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at...

Simulations Plus (NASDAQ:SLP) Shares Gap Up  After Strong Earnings

Q2 2024 Simulations Plus Inc Earnings Call Transcript

Simulations Plus stock jumps 25% amid FDA renewal, earnings report...

Simulations Plus stock jumps 25% amid FDA renewal, earnings report

In trading on Thursday, shares of Simulations Plus Inc (SLP) crossed above their 200 day moving average of 42.11, changing hands as high as 47.87 per share. Simulations Plus Inc shares are...

Bullish Two Hundred Day Moving Average Cross - SLP

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Simulations Plus backs FY24 EPS view 66c-68c, consensus 66c

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

Volume (M)	98,448.00
52-Wk High	$52.69
52-Wk Low	$32.69

SLP Simulations Plus Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals